SC Laboratories offers expert consultation to dispensaries and producers on developing labels for Medical Cannabis flowers and products to clearly inform patients as to which Cannabinoids (THC, CBD, CBN etc.) are included in their medicine and in what amounts. 

Clear labeling allows both patients and their health care practitioner to meter out a specific dose to exactly meet their medical needs. This is especially important because of the many different ways in which medicine can be delivered. The cannabinoids are absorbed and distributed throughout the body when ingested thru non-traditional delivery routes. For example, when eaten, THC is metabolized by the liver which produces 11-hydroxy THC as a byproduct. As a result, consuming cannabis orally can have psychoactive effects up to 5x greater than the effect of ingesting the same amount by smoking.

Because Medical Cannabis is produced and processed in a manner closer to the agricultural industry than the pharmaceutical industry, SC Laboratories uses FDA requirements as a template for its labeling requirements and procedures. The FDA requires each label to be scientifically accurate and provide clear instruction to health care practitioners for prescription drugs and to consumers for over-the-counter drugs and supplements.

Labeling recommendations include:

• The statement of ingredients must include all ingredients, in the order in which they are used in the drug
• These ingredients must be identified by their established name
• The name of the medicine along with any critical warnings must be given top billing
• The label must describe the uses of the medicine along with the conditions under which the medicine should not be used
• The consumer must be given directions for the contraindications

Currently there are no such labeling requirements for medical cannabis!